2025-12-19 - Analysis Report
Okay, here's a report summarizing the provided data on Salesforce (CRM), along with analysis:

**1. Return Rate Comparison:**

*   **Company Overview:** Salesforce (CRM) is a global leader in cloud-based software, providing customer relationship management (CRM) solutions.
*   **CRM Cumulative Return:** -4.87%
*   **VOO (S&P 500) Cumulative Return:** 99.09%
*   **Divergence:** -105.8 (Relative Divergence: 6.5)

**Analysis:**  CRM has significantly underperformed the S&P 500 (VOO) over the period examined.  The divergence of -105.8 indicates a substantial difference in cumulative returns. The relative divergence of 6.5 suggests the current divergence is near the minimum seen in the historical range of divergence data provided.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
|------------|--------|-------|--------|-------|--------|
| 2015-2017  | 39.0%  | 70.6% | 10.0%  | -0.0  | 97.3   |
| 2016-2018  | 34.0%  | 73.5% | 19.0%  | 0.1   | 130.4  |
| 2017-2019  | 22.0%  | 73.5% | 0.0%   | 0.4   | 154.8  |
| 2018-2020  | 14.0%  | 73.5% | -10.0% | 0.4   | 211.8  |
| 2019-2021  | 37.0%  | 71.9% | -10.0% | 0.7   | 241.9  |
| 2020-2022  | -78.0% | 74.7% | -78.0% | 0.4   | 126.2  |
| 2021-2023  | -47.0% | 76.6% | -49.0% | -0.6  | 250.5  |
| 2022-2024  | -42.0% | 76.6% | -63.0% | -0.4  | 318.3  |
| 2023-2025  | 6.0%   | 76.6% | -57.0% | -2.1  | 245.5  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate (CAGR) shows a wide range of performance, with strong growth in earlier periods and significant declines in more recent ones.
*   **MDD:** Maximum Drawdown (MDD) is consistently high, indicating significant risk and volatility.
*   **Alpha:** Alpha is negative for the more recent periods, meaning the stock has underperformed relative to its risk (Beta).
*   **Beta:** Beta fluctuates. A Beta near 0 means the price is relatively independent of market movement, while a Beta near 1 means the price moves with the market. A negative beta is the opposite of the overall market.
*   **Cap(B):** Market Capitalization generally increased until 2022, before declining and showing only a slight increase.

**2. Recent Stock Price Fluctuations:**

*   **Current Close:** 257.85
*   **Previous Close:** 257.72
*   **Change:** 0.05
*   **5-day SMA:** 257.54
*   **20-day SMA:** 246.87
*   **60-day SMA:** 245.93

**Analysis:** The stock price is slightly up compared to the previous day. The 5-day Simple Moving Average (SMA) is slightly above the 20-day and 60-day SMAs, suggesting a possible short-term upward trend.

**3. RSI, PPO, and Expected Return Analysis:**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment)
*   **RSI:** 76.99 (Overbought territory)
*   **PPO:** 0.42
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80) (Cash Ratio: 0% on 2025-12-02)
*   **Recent (20 days) relative divergence change:** -0.6 (Short-term decline)
*   **Expected Return (%):** -691.4%

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI above 70 indicates that the stock is currently overbought, which could suggest a potential pullback.
*   The negative relative divergence change over the past 20 days suggests recent weakness.
*   The Hybrid Signal is an aggressive buy signal.
*   The extremely negative expected return is a major red flag, suggesting very poor long-term prospects based on this analysis.

**4. Recent News & Significant Events:**

*   The news headlines reflect a mix of information:
    *   **Stock Price Fluctuations:** Several articles discuss after-hours stock price movements and factors influencing them, including AI thesis and analyst forecasts.
    *   **Insider Activity:** One article mentions insider moves, which can be an indicator of management's sentiment about the company's future.
    *   **AI Focus:**  One headline highlights JPM's view that the market is underestimating Salesforce's AI potential.
    *   **Agentforce Updates:**  Several articles focus on Salesforce's Agentforce platform and related deals/forecasts, indicating its importance.

**Analysis:** The news suggests some volatility in the stock price, but also a continued focus on AI as a key growth driver. Analyst opinions seem to be generally bullish on the AI aspect. The focus on Agentforce indicates it is a key area of development and interest.

**4-2. Analyst Opinions:**

*   **Consensus:** Buy
*   **Mean Rating:** 1.64 (Buy)
*   **Opinions:** 53
*   **Target Price:** 330.06 (Average), 475.00 (High), 223.00 (Low)
*   **Recent Rating Changes:** No changes

**Analysis:**  Analysts generally have a "Buy" rating on the stock with a substantial upside potential based on the average target price. The lack of recent rating changes suggests a consistent outlook.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-12-04 | 2.2  | 10.26 B$    |
| 2025-09-04 | 1.97 | 10.24 B$    |
| 2025-05-29 | 1.61 | 9.83 B$     |
| 2024-12-04 | 1.6  | 9.44 B$     |
| 2025-12-04 | 1.6  | 9.44 B$     |

**Analysis:**

*   Earnings Per Share (EPS) has generally been increasing over the last several quarters.
*   Revenue has also been trending upward.
*   Duplicated dates (2024-12-04 and 2025-12-04 showing same values) raise concerns about data accuracy.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue     | Profit Margin |
|--------------|-------------|---------------|
| 2025-10-31   | $10.26B     | 78.02%        |
| 2025-07-31   | $10.24B     | 78.10%        |
| 2025-04-30   | $9.83B      | 76.96%        |
| 2025-01-31   | $9.99B      | 77.81%        |
| 2024-10-31   | $9.44B      | 77.71%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE     |
|--------------|-------------|---------|
| 2025-10-31   | $60.02B     | 3.48%   |
| 2025-07-31   | $61.33B     | 3.08%   |
| 2025-04-30   | $60.67B     | 2.54%   |
| 2025-01-31   | $61.17B     | 2.79%   |
| 2024-10-31   | $58.52B     | 2.61%   |

**Analysis:**

*   **Revenue:** Consistent growth in revenue over the quarters.
*   **Profit Margin:** Consistently high profit margins, indicating strong profitability.
*   **Equity:**  Fluctuates slightly.
*   **ROE:** Return on Equity (ROE) has shown a recent increase, indicating improved efficiency in generating profits from equity.

**7. Comprehensive Analysis:**

*   **Underperformance:** CRM has significantly underperformed the S&P 500 recently.
*   **Volatility:** The stock exhibits high volatility, as evidenced by the MDD.
*   **Mixed Signals:** While analysts have a generally positive outlook ("Buy" rating, upside target price), the technical indicators (overbought RSI, negative divergence, and drastically negative expected return) paint a more cautious picture.
*   **Financial Health:** The company demonstrates strong and growing revenue, excellent profit margins, and generally healthy equity. However, it is necessary to have the duplicated dates (2024-12-04 and 2025-12-04 showing same values) corrected.
*   **AI Focus:** News headlines and analyst commentary suggest a strong focus on Salesforce's AI capabilities as a key growth driver.
*   **Conflicting Indicators:** A key issue is the conflict between analyst ratings and the very negative expected return. This suggests that while analysts are optimistic about the company's fundamentals and future potential, there may be significant short-term risks or specific factors not captured in the analyst consensus.

**Conclusion:** CRM presents a complex picture. While the company has strong fundamentals (revenue growth, high profit margins) and is positioned in a growing market (AI), the recent underperformance, high volatility, and conflicting technical indicators suggest caution is warranted. Investors should carefully weigh the positive analyst outlook against the potential risks before making an investment decision. The negative expected return is a significant concern that needs further investigation. Also, it is necessary to have the duplicated dates (2024-12-04 and 2025-12-04 showing same values) corrected.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.